SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-10
👔
Cue Biopharma, Inc.
@CUE_InsiderForm 4 Filing: Meluzio Michael Vincent Acquires (Grant) shares of $CUE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Cue Biopharma, Inc.
Ticker: $CUE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-09
Shares: 40,942
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Meluzio Michael Vincent, holds the title of VP, Prin. Accounting Officer at Cue Biopharma, Inc..
On 2026-07-09, the insider transacted 40,942 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Meluzio Michael Vincent (VP, Prin. Accounting Officer) was granted $0 of $CUE
Post-Transaction Position: 40,942 shares
SEC Accession No: 0002138368-26-000005 (CIK: 2138368)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.